NCT00017342View on ClinicalTrials.gov

Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2001

Primary Completion Date

September 30, 2004

Study Completion Date

June 30, 2005

Conditions
Leukemia
Interventions
DRUG

bryostatin 1

DRUG

cytarabine

Trial Locations (4)

10021

New York Weill Cornell Cancer Center at Cornell University, New York

10032

Herbert Irving Comprehensive Cancer Center at Columbia University, New York

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

23298-0037

Massey Cancer Center at Virginia Commonwealth University, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Virginia Commonwealth University

OTHER

NCT00017342 - Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia | Biotech Hunter | Biotech Hunter